A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia

PHASE2CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Pain
Interventions
DRUG

[S,S]-Reboxetine

Trial Locations (61)

16602

Pfizer Investigational Site, Altoona

17011

Pfizer Investigational Site, Camp Hill

18015

Pfizer Investigational Site, Bethlehem

19020

Pfizer Investigational Site, Bensalem

19713

Pfizer Investigational Site, Newark

23455

Pfizer Investigational Site, Virginia Beach

27511

Pfizer Investigational Site, Cary

27609

Pfizer Investigational Site, Raleigh

28210

Pfizer Investigational Site, Charlotte

29572

Pfizer Investigational Site, Myrtle Beach

32720

Pfizer Investigational Site, DeLand

33407

Pfizer Investigational Site, West Palm Beach

33606

Pfizer Investigational Site, Tampa

33614

Pfizer Investigational Site, Tampa

34471

Pfizer Investigational Site, Ocala

34474

Pfizer Investigational Site, Ocala

37203

Pfizer Investigational Site, Nashville

38358

Pfizer Investigational Site, Milan

40509

Pfizer Investigational Site, Lexington

43623

Pfizer Investigational Site, Toledo

45219

Pfizer Investigational Site, Cincinnati

45227

Pfizer Investigational Site, Cincinnati

45402

Pfizer Investigational Site, Dayton

46250

Pfizer Investigational Site, Indianapolis

53209

Pfizer Investigational Site, Milwaukee

58701

Pfizer Investigational Site, Minot

60031

Pfizer Investigational Site, Gurnee

61265

Pfizer Investigational Site, Moline

63141

Pfizer Investigational Site, St Louis

64106

Pfizer Investigational Site, Kansas City

65109

Pfizer Investigational Site, Jefferson City

67124

Pfizer Investigational Site, Pratt

68516

Pfizer Investigational Site, Lincoln

77024

Pfizer Investigational Site, Houston

77030

Pfizer Investigational Site, Houston

77566

Pfizer Investigational Site, Lake Jackson

78213

Pfizer Investigational Site, San Antonio

78229

Pfizer Investigational Site, San Antonio

78626

Pfizer Investigational Site, Georgetown

84102

Pfizer Investigational Site, Salt Lake City

85007

Pfizer Investigational Site, Phoenix

85013

Pfizer Investigational Site, Phoenix

85225

Pfizer Investigational Site, Chandler

85351

Pfizer Investigational Site, Sun City

85741

Pfizer Investigational Site, Tucson

93449

Pfizer Investigational Site, Pismo Beach

94598

Pfizer Investigational Site, Walnut Creek

95602

Pfizer Investigational Site, Auburn

95662

Pfizer Investigational Site, Orangevale

97401

Pfizer Investigational Site, Eugene

97504

Pfizer Investigational Site, Medford

98201

Pfizer Investigational Site, Everett

98405

Pfizer Investigational Site, Tacoma

02720

Pfizer Investigational Site, Fall River

02048

Pfizer Investigational Site, Mansfield

02481-2106

Pfizer Investigational Site, Wellesley Hills

01610

Pfizer Investigational Site, Worcester

10022-1009

Pfizer Investigational Site, New York

28209-3734

Pfizer Investigational Site, Charlotte

16635-0909

Pfizer Investigational Site, Duncansville

02864

Pfizer Investigational Site, Cumberland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00357825 - A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia | Biotech Hunter | Biotech Hunter